97 results
8-K
BPTH
Bio-Path Holdings Inc
3 Jun 24
Other Events
7:10am
-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
3 Jun 24
Other Events
7:10am
at American Society of Clinical Oncology (ASCO) Annual Meeting
Positive Results from Interim Analysis Demonstrate Significant Clinical Improvement … for the treatment of acute myeloid leukemia (AML) in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, on June 1, 2024
8-K
BPTH
Bio-Path Holdings Inc
30 May 24
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
4:10pm
titled, “Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting.” A copy of such press release is attached
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
30 May 24
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
4:10pm
Exhibit 99.1
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
Presentation Includes Positive … of targeted nucleic acid cancer drugs, today announced an upcoming oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
424B5
vk0qq wu8u
19 Apr 24
Prospectus supplement for primary offering
3:28pm
424B5
sm8y m3mg
19 Apr 24
Prospectus supplement for primary offering
9:17am
424B5
6xfury 1y9m71
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
vjuyqxj8h
27 Mar 24
Prospectus supplement for primary offering
8:15am
424B3
y6xty5fjdh47 hrx
7 Aug 23
Prospectus supplement
7:21am
424B4
nrq6s aql24e6u1
7 Aug 23
Prospectus supplement with pricing info
7:16am